In the STEP-4 (Effect and Safety of Semaglutide 2.4 mg Once-Weekly in Subjects With Overweight or Obesity Who Have Reached Target Dose During Run-in Period) trial, 16 participants who discontinued semaglutide after 20 weeks regained a mean 6.9% of their baseline body weight over 48 weeks
These medications are not suitable for everyone, especially people with a history of certain medical conditions
These results, while successful, werent quite as impressive as many had hoped
Salt Composition: Semaglutide (7mg) Strength: Semaglutide (7mg) Pack Size: strip of 10 tablets Uses: Treatment of Type 2 diabetes mellitus DISCLAIMER Product information is meant for Related Products Human Zinulin 40IU/ml Injection is used to improve blood sugar control in adults and children with type 1 and type 2 diabetes mellitus
What the Current Clinical Evidence Shows Phase 2 trial data published in the NEJM in 2023 show gastrointestinal events including nausea were the most common side effects, were transient and self-limiting in most participants, and were more frequent at higher doses